In conclusion, T3 as well as the selective THR-β agonist RES decreased Acbp/Dbi expression and reversed metabolic signs of Cushing’s syndrome. This evidence concerns the gene DBI and Cushing syndrome due to macronodular adrenal hyperplasia.